<DOC>
	<DOCNO>NCT02550288</DOCNO>
	<brief_summary>This study evaluate efficacy safety MK-0653C ( Ezetimibe [ EZ ] 10 mg/Atorvastatin [ Atora ] 10mg 20 mg ) compare EZ 10 mg , Atora 10 mg , Atora 20 mg alone administer Japanese participant hypercholesterolemia . The primary hypothesis MK-0653C ( EZ 10 mg/Atorva 10 mg ) superior EZ 10 mg superior Atorva 10 mg MK-0653C ( EZ 10 mg/Atorva 20 mg ) superior EZ 10 mg superior Atorva 20 mg percent change baseline low-density lipoprotein cholesterol ( LDL-C ) 12 week treatment .</brief_summary>
	<brief_title>A Clinical Trial Assess Efficacy Safety MK-0653C Japanese Participants With Hypercholesterolemia ( MK-0653C-383 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Japanese outpatient hypercholesterolemia . Females must nonreproductive potential agree remain abstinent use ( partner use ) two acceptable method birth control date sign informed consent 14 day last dose study drug Agree maintain stable diet consistent Japan Atherosclerosis Society Guideline 2012 ( JAS2012 ) prevention atherosclerotic cardiovascular disease duration study Uncontrolled hypertension Type 1 uncontrolled type 2 diabetes mellitus ( treat untreated ) History coronary artery disease ( CAD ) Homozygous familial hypercholesterolemia undergone LDL apheresis Had gastrointestinal tract bypass , significant intestinal malabsorption History cancer within past 5 year except successfully treat dermatological basal cell squamous cell carcinoma situ cervical cancer Human immunodeficiency virus ( HIV ) positive History drug/ alcohol abuse within past 5 year psychiatric illness adequately control stable pharmacotherapy Consumes 25 g alcohol per day Consumes 1L grapefruit juice per day Currently follow excessive weight reduction diet Engaging vigorous exercise regimen ( e.g . ; marathon training , body build train etc . ) intend start training study Hypersensitivity intolerance ezetimibe atorvastatin History myopathy rhabdomyolysis ezetimibe statin Pregnant lactating Taking investigational drug and/or take investigational drug within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>